🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The WHO recommends artesunate as the drug of choice for the treatment of se...
Status
Completed
Location
Allama Iqbal Teaching Hospital
Start Date
2023-03-01
Trial ID
NCT06472258
Treatments Being Tested
The spread of artemisinin resistant falciparum malaria presents new challen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02640495
Treatments Being Tested
The study aims at describing the pharmacokinetic properties of rectal artes...
Status
Completed
Location
Kinshasa School of Public Health
Start Date
2015-07
Trial ID
NCT02492178
Treatments Being Tested
This study evaluates the efficacy and safety of 3 months of malaria chemopr...
Status
Completed
Location
Homa Bay County Referral Hospital
Start Date
2016-05-20
Trial ID
NCT02671175
Treatments Being Tested
Proposal for Sub-Study to be conducted with the WHO Solidarity Plus Trial: ...
Status
Unknown
Location
Chitwan Medical College
Start Date
2021-12-06
Trial ID
NCT05273242
Treatments Being Tested
The present study aims to investigate and to assess possible neurological a...
Status
Completed
Location
Centre Mère et Enfant, Fondation Chantal Biya
Start Date
2007-12
Trial ID
NCT00978172
Treatments Being Tested
The purpose of this study was to identify the safe and effective dose of in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-07
Trial ID
NCT04675931
Treatments Being Tested
The purpose of this study is to determine how GMP IV Artesunate is metaboli...
Status
Completed
Location
New Nyanza Provincial Hospital
Start Date
2006-03
Trial ID
NCT00298610
Treatments Being Tested
This study is an adaptive, randomized, open-label, controlled clinical tria...
Status
Unknown
Location
Peter Lougheed Centre
Start Date
2020-03-18
Trial ID
NCT04330690
Treatments Being Tested
This study is a randomized, open-label, active comparator-controlled, dose-...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-08-01
Trial ID
NCT06853184
Treatments Being Tested